Literature DB >> 21705022

Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease.

Henk W Berendse1, Dareia S Roos, Pieter Raijmakers, Richard L Doty.   

Abstract

Hyposmia is highly prevalent in the motor phase of Parkinson's disease (PD) and is an established pre-motor sign of PD that may precede the onset of motor symptoms by as long as 5 years. The data presented here are part of an ongoing study to determine the relationship of the olfactory deficit in PD with both motor and non-motor features of the disease. The study population so far includes 96 patients with a clinical diagnosis of PD (UK PD Society Brain Bank criteria; mean age 64.9 years; mean disease duration 4.8 years). Olfactory testing was performed using the 40-item UPSIT. We analyzed the relationship between UPSIT scores and measures of motor (disease duration, stage and severity) and non-motor (cognitive function, depression, anxiety and sleep) function. In 60 PD patients, [(123)I]FP-CIT SPECT scans were available to assess the relationship between UPSIT scores and striatal dopamine transporter (DAT) binding. Preliminary analyses revealed correlations of the olfactory deficit in PD with both motor and non-motor features, as well as with striatal DAT binding. These data suggest that the olfactory deficit in PD is not stationary by the time the motor phase is entered, but continues to progress over time. Hyposmia may therefore be useful as a marker of disease progression, at least in the early disease stages.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21705022     DOI: 10.1016/j.jns.2011.06.020

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  36 in total

1.  Prevalence of impaired odor identification in Parkinson disease with imaging evidence of nigrostriatal denervation.

Authors:  Jacob Haugen; Martijn L T M Müller; Vikas Kotagal; Roger L Albin; Robert A Koeppe; Peter J H Scott; Kirk A Frey; Nicolaas I Bohnen
Journal:  J Neural Transm (Vienna)       Date:  2016-02-24       Impact factor: 3.575

2.  Correlation among olfactory function, motors' symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson's disease.

Authors:  Carla Masala; Paolo Solla; A Liscia; G Defazio; L Saba; A Cannas; A Cavazzana; T Hummel; A Haehner
Journal:  J Neurol       Date:  2018-05-26       Impact factor: 4.849

3.  Does the cycad genotoxin MAM implicated in Guam ALS-PDC induce disease-relevant changes in mouse brain that includes olfaction?

Authors:  Glen Kisby; Valerie Palmer; Mike Lasarev; Rebecca Fry; Mihail Iordanov; Eli Magun; Leona Samson; Peter Spencer
Journal:  Commun Integr Biol       Date:  2011-11-01

4.  Olfactory impairment predicts cognitive decline in early Parkinson's disease.

Authors:  Michelle E Fullard; Baochan Tran; Lama M Chahine; James F Morley; Sharon X Xie; Jon B Toledo; Christi Scordia; Carly Linder; Rachael Purri; Daniel Weintraub; John E Duda
Journal:  Parkinsonism Relat Disord       Date:  2016-02-19       Impact factor: 4.891

5.  Hyposmia may predict development of freezing of gait in Parkinson's disease.

Authors:  Jae Jung Lee; Jin Yong Hong; Jong Sam Baik
Journal:  J Neural Transm (Vienna)       Date:  2021-05-20       Impact factor: 3.575

Review 6.  Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease.

Authors:  Michelle E Fullard; James F Morley; John E Duda
Journal:  Neurosci Bull       Date:  2017-08-22       Impact factor: 5.203

7.  Long-Term Systemic Exposure to Rotenone Induces Central and Peripheral Pathology of Parkinson's Disease in Mice.

Authors:  Shinki Murakami; Ikuko Miyazaki; Ko Miyoshi; Masato Asanuma
Journal:  Neurochem Res       Date:  2015-04-18       Impact factor: 3.996

Review 8.  Olfactory dysfunction: common in later life and early warning of neurodegenerative disease.

Authors:  Karl-Bernd Hüttenbrink; Thomas Hummel; Daniela Berg; Thomas Gasser; Antje Hähner
Journal:  Dtsch Arztebl Int       Date:  2013-01-07       Impact factor: 5.594

9.  Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease.

Authors:  Rui Liu; David M Umbach; Alexander I Tröster; Xuemei Huang; Honglei Chen
Journal:  Parkinsonism Relat Disord       Date:  2020-02-11       Impact factor: 4.891

Review 10.  Olfactory loss as a supporting feature in the diagnosis of Parkinson's disease: a pragmatic approach.

Authors:  Katie Hoyles; Jagdish C Sharma
Journal:  J Neurol       Date:  2013-02-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.